✨ Your Portfolio is fetched and updated from zerodha.
Mid

Biocon Ltd.

BIOCON

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹47,048 Cr.
P/E
122.20

Biocon Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
47,048 Cr
PE
PE
122
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
4.68
ROCE (%)
ROCE (%)
6.08
Div Yield (%)
Div Yield (%)
0.63
Sales
Sales
15,770 Cr
OPM (%)
OPM (%)
20.70 %
Debt to Equity
Debt to Equity
-
View more
Edit Ratio's
About
Biocon is in the Miscellaneous sector with a M.cap of 47048.00 Cr and a PE ratio of 12… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Biocon Ltd. Business

Biocon Limited is a global biopharmaceuticals company focusing on developing and manufacturing innovative biologics, biosimilars, and APIs for chronic conditions. They also have a pipeline of novel assets in immunotherapy.

Biocon major competitors are Concord Biotech, Advanced Enzyme, Fermenta Biotech, Glaxosmithkline Phar, Glenmark Pharma, Ipca Laboratories, Aurobindo Pharma.
Market Cap of Biocon is ₹47,135 Crs.
While the median market cap of its peers are ₹34,652 Crs.

Biocon seems to be less financially stable compared to its competitors.
Altman Z score of Biocon is 1.56 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice
Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Aug Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Investor Presentation May Aug Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Apr Jun Jul Sep Dec Jan Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material